|Videos|August 27, 2021
Change your thinking for glycosylation
Author(s)Roche
Advertisement
Traditional protein production involves the management of many variables for two separate outcomes: a high protein yield and the desired glycosylation. With the right tools, glycosylation can be uncoupled from fermentation. Roche CustomBiotech calls this in-vitro glycoengineering, or IVGE. This video will explain a little more about the paradigm changing IVGE.
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
How FDA’s Bayesian Guidance Could Accelerate Adaptive Trial Design in Biopharmaceuticals
2
Why Biotech’s Clinical Maturity Is Driving New Partnerships and Capacity Plays
3
Agenus Closes $141 Million Immunotherapy Collaboration with Zydus Lifesciences
4
Johnson & Johnson Announces Second $2 Billion Manufacturing Facility in North Carolina
5
